Your session is about to expire
← Back to Search
Chemotherapy + Radiation for Pancreatic Cancer
Study Summary
This trial is testing whether adding chemotherapy and radiation to the standard of care for resectable pancreatic cancer can improve the chances of surgeons achieving an R0 resection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 trial • 29 Patients • NCT02045446Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had any cancer except for minor skin cancers or cancers cured by surgery or surgery plus radiotherapy in the last 5 years.My diagnosis is pancreatic adenocarcinoma.My blood, kidney, and liver tests are within the required ranges.I do not have any serious infections that need treatment with medication.I am 18 years old or older.My cancer is at a stage where surgery might not remove it all, or it has spread.I haven't needed IV antibiotics for an infection when starting this study.I have never been treated for pancreatic cancer before.My tumor can possibly be removed with surgery.I am fully active or restricted in physically strenuous activity but can do light work.
- Group 1: Chemotherapy and SBRT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are volunteers still needed for this experiment?
"That is correct, the online information hosted on clinicaltrials.gov affirms that this trial is currently looking for participants. This specific study was originally posted on July 17th, 2019 and has had recent activity on June 14th, 2022. Out of the 30 total spots available, 1 site still needs patients."
What cancerous growths does Stereotactic Body Radiation Therapy help to eliminate?
"Stereotactic Body Radiation Therapy can offer patients with neoplasm metastasis, locally advanced non-small cell lung cancer, and metastatic bladder cancer a chance at treatment."
What is the total number of patients that are participating in this clinical trial?
"Yes. The clinicaltrials.gov website has updated information that this trial is still looking for patients. This particular study was first posted on 7/17/2019, with the most recent changes made on 6/14/2022. They are enrolling 30 participants from 1 site."
What is the history of research using Stereotactic Body Radiation Therapy?
"Currently, there are 1164 active clinical trials for Stereotactic Body Radiation Therapy (SBRT), with 330 of those trials in Phase 3. While several of the SBRT clinical trials are located in Shanghai, there are a total of 59839 locations running SBRT trials worldwide."
Has Stereotactic Body Radiation Therapy undergone FDA approval process?
"While Phase 2 trials don't have the same level of data supporting efficacy, our team at Power has evaluated the available safety data and given Stereotactic Body Radiation Therapy a score of 2."
Share this study with friends
Copy Link
Messenger